We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA, FDA Offer Opinions, Advice on Proposed Research Methods
EMEA, FDA Offer Opinions, Advice on Proposed Research Methods
February 4, 2009
The European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use (CHMP) can give drug developers a qualification opinionon specific uses of a proposed research method, such as biomarkers or new imaging methods, or qualification advice on future protocols and methods, according to a final guidance.